This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. In this issue of Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE), four medical imaging innovations are profiled, along with IP analyses, and a snapshot of the patent landscape. For each of the technologies – high-frequency ultrasound imaging, breast-specific magnetic resonance imaging, image-guided procedure, and elastography â...

    $950.00
  2. This edition of the Genetic Technology TOE depicts innovations in 3D printing of pharmaceutical products. Different technology platforms and diverse applications are illustrated. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D de...

    $250.00
  3. This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across emerging cancer immunotherapies in the United States, from personalized cancer vaccines to novel targeted therapies. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision...

    $250.00
  4. 15 Apr 2016  |  Global  |  Technology Alert

    Smart-Cutaneous Wearables-Medical Device Alert

    This edition of Medical Device Alert depicts trends across smart-cutaneous wearables, with advancements in health monitoring. The patent scenario for each technology profiled is also depicted. The Medical Device Alert analyses and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to n...

    $950.00
  5. 08 Apr 2016  |  Global  |  Technology Alert

    Novel Drug Delivery Systems in the Spotlight-Drug Discovery Alert

    This edition of Drug Discovery Alert depicts life sciences trends across novel drug delivery systems (NDDS). The physiochemical properties of some powerful novel therapeutics such as poor solubility and poor permeation can at times leads to mistargeting at the active site. This concern generates a barrier for therapeutic efficacy. Various nanoformu...

    $950.00
  6. This edition of the Genetic Alert depicts the current landscape and the new life sciences trends across proteomic and molecular diagnostic technologies. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit...

    $250.00
  7. This edition of the Medical and Diagnostics Imaging Alert depicts key innovations in the European Union. Innovations from well renowned institutions including the University of St. Andrews, the University of Nottingham, and the University of Glasgow, as well as, important companies comprising Med Imaging Limited, Planmed Oy, Elekta Instrument AB, ...

    $950.00
  8. 25 Mar 2016  |  Global  |  Technology Alert

    Software Platforms for Proteomics in North America-Genetic Alert

    This edition of the Genetic Alert depicts the current landscape and new life sciences trends across software platforms for proteomics in the North American region. The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer,...

    $250.00
  9. 18 Mar 2016  |  Global  |  Technology Alert

    Innovations in Medical Devices in Singapore-Medical Device Alert

    This edition of Medical Device Alert depicts innovations in medical devices in Singapore. A broad spectrum of technologies are depicted, including 3D bioprinting, prosthetic heat valves, wireless neural implants, robotic-based surgery, and diagnostic kits. Industry contacts and collaborations are also illustrated. The Medical Device Alert analyse...

    $950.00
  10. This edition of the Genetic Alert depicts genetic advances in lung cancer detection and treatment. The study profiles a series of innovative technologies including genetic mutations identification, as well as, novel biomarkers and inhibitors. Analyst insights on genetic advances in lung cancer detection and treatment are included. The corresponding...

    $250.00